Economic Analyses of Policies to Reduce Cervical Cancer

Over the last few decades, the cervical cancer incidence and mortality rates have declined in many countries, including Canada. The improvements have been attributed, in part, to higher rates of cervical cancer screening and the implementation of population-level HPV vaccine strategies.

This rapid synthesis, requested by the Canadian Partnership Against Cancer, has collected evidence on costs or cost-effectiveness of population-level programs and policies aimed at reducing cervical cancer incidence.